Idexx Laboratories (IDXX) Receivables - Other (2018 - 2026)

Idexx Laboratories' Receivables - Other history runs 9 years deep, the most recent figure standing at $77.7 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 23.47% year-over-year to $77.7 million; the TTM figure through Mar 2026 stood at $77.7 million (up 23.47% YoY), while the FY2025 annual figure was $75.8 million, up 24.82% from the prior year.
• Receivables - Other for Q1 2026 stood at $77.7 million, up from $75.8 million in the prior quarter.
• The five-year high for Receivables - Other was $77.7 million in Q1 2026, with the low at $40.4 million in Q2 2022.
• The 5-year median for Receivables - Other is $56.6 million (2024), against an average of $56.6 million.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 56.51% in 2022, then gained 10.23% in 2024.
• Idexx Laboratories' Receivables - Other stood at $41.9 million in 2022, then soared by 31.67% to $55.1 million in 2023, then grew by 10.23% to $60.8 million in 2024, then climbed by 24.82% to $75.8 million in 2025, then climbed by 2.47% to $77.7 million in 2026.
• Business Quant data shows IDXX's Receivables - Other at $77.7 million in Q1 2026, $75.8 million in Q4 2025, and $72.0 million in Q3 2025.